Company Summary - United Drug PLC (ISE:UN6A)
€2.18
€0.00
Food & Drug RetailersMarket cap: €520.283m
NEW Explore our new and improved report for United Drug PLC >>
Gain access to various premium features such as detailed information on financial reports, broker forecasts, directors and shareholders information.
Summary
Healthcare services provider
| Financials - Annual Report (30/09/2011) | ||
|---|---|---|
| Turnover | €m | 1,746.45 |
| Pre-tax Profit | €m | 44.16 |
| EPS | € | 19.04 |
| DPS | € | 8.47 |
| Dividend Yield | % | 3.885 |
| Director | Board Role |
|---|---|
| Peter Gray | Chairman |
| Liam FitzGerald | Chief Executive |
| Barry McGrane | Finance Director |
Products Brands & Subsidiaries
Products & Brands
There are no products for this company.
Subsidiaries
United Drug Wholesale Ltd; Pemberton Marketing International Ltd; Unitech Ltd; United Drug (UK) Holdings Ltd...
Broker Sentiment (2 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Holding in Company | 09/02/2012 |
| Holding in Company | 08/02/2012 |
| Peter Gray Succeeds Ronnie Kells ... | 07/02/2012 |
For more information
and investor relations, visit the
United Drug PLC company website: